Skip to menu Skip to content Skip to footer
Professor Hemamali Samaratunga
Professor

Hemamali Samaratunga

Email: 

Overview

Background

Hemamali Samaratunga MBBS (Hons) LRCP (London) MRCS (UK) FRCPA, FRCPath

  • Specialist Anatomical Pathologist, Managing Director, Aquesta Specialised Uropathology
  • Full Professor, University of Queensland Faculty of Medicine
  • Visiting Medical Officer, Greenslopes Private Hospital

Hemamali graduated with honours from the University of Sri Lanka, Colombo Medical School and completed Pathology specialty training in Queensland. She held a number of consultant posts in both hospital and private practice. In 2008 she established Aquesta Uropathology which now provides diagnostic uropathology services to the majority of urologists in Queensland and Northern New South Wales. In addition to this she maintains a large second opinion consultation practice with requests obtained from throughout Australia and from overseas.

She is active in Genitourinary Pathology research with collaborators in Australia, USA, Canada, Karolinska Institute in Sweden and the Wellington School of Medicine in New Zealand. She held the position of Secretary of the International Society of Urological Pathology from 2015 to 2019.

She was a contributor to the 2004, 2015 and 2022 World Health Organization (WHO) books on Classification of Tumours: Pathology and Genetics of Tumours of the Urinary and Male Reproductive System. She participated in the 2015 revision of the WHO Tumour Classification in Zurich, Switzerland (4th edition) as member, Prostate Tumour Panel. She was a representative of the Expert Groups formulating structured reporting protocols for the Royal College Pathologists of Australasia on kidney, testis and prostate cancer and is currently chairperson of the structured reporting protocols for Genitourinary cancer. She is also currently the Convener for the RCPA Uropathology Quality Assurance Program.

Qualifications

MBBS (HONS) LRCP (London) MRCS (UK) FRCPA FRCPath

Current UQ Appointments

Academic Title-Professor

Non-UQ Appointments

2008 - current: Specialist Anatomical Pathologist & Managing Director, Aquesta Specialized Uropathology

2015 - Current: Visiting Medical Officer, Greenslopes Private Hospital

2003 - 2021: Visiting Medical Officer, Princess Alexandra Hospital

June 2001 - Oct 2008: Specialist Anatomical Pathologist, Sullivan Nicolaides Pathology, Brisbane

1993 - 1997: Specialist Anatomical Pathologist, Royal Brisbane Hospital

1998 - 2001: Senior Anatomical Pathologist, North Brisbane Hospitals Board

Research Interests

  • Granular tumour necrosis
  • Diagnosis of limited adenocarcinoma on prostate needle biopsy
  • Ductal adenocarcinoma of prostate
  • Mucinous adenocarcinoma of prostate
  • Radical prostatectomy handling and reporting
  • Micropapillary urothelial cancer
  • Mimics of bladder cancer

Awards and other Esteem Indicators

2017 Admitted to Fellowship of the Royal College of Pathologists, London (FRC Path) for sustained excellence in published works

2022 Awarded the Grawitz Medal of the International Society of Urological Pathology for distinguished service to the discipline of Urological Pathology

2023 Author of the publication Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: Ten year data from the TROG 03.04 RADAR Trial. Pathology 54: 49- 54, awarded the prize of

Article of the Year by the Royal College of Pathologists of Australasia.

2024 Distinguished Fellowship Award of the Royal College Pathologists of Australasia

For distinguished service to the discipline of Urological Pathology

Keywords

Pathology, Genitourinary cancer, Prostate, Kidney, Urinary tract, Testis, Penis

Availability

Professor Hemamali Samaratunga is:
Available for supervision

Research impacts

She has over 320 scientific publications and has a Google Scholar H-index of 56 with 18150 citations. To date she has authored or co-authored 28 books, 21 book chapters and 274 peer-reviewed publications. Apart from her primary research activities Professor Samaratunga actively collaborates with other research groups and is a regular contributor - often as primary or senior author to international research consortia. One notable contribution has been her involvement in the development of artificial intelligence programs for the reporting of prostate cancer. In collaborative studies involving colleagues from the Netherlands, Sweden, Australia, New Zealand and the United States she was chosen to be one of three expert pathologists to review all cases, thus setting the gold standard for the diagnosis and grading of prostate cancer. These studies have been published in highly prestigious journals as noted in her CV. Importantly in comparative studies, the AI program informed by the findings of group of three pathologists that included Professor Samaratunga, outperformed all other AI programs.

Works

Search Professor Hemamali Samaratunga’s works on UQ eSpace

294 works between 1988 and 2024

121 - 140 of 294 works

2017

Journal Article

Editorial comment to biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam

Egevad, Lars, Samaratunga, Hemamali and Delahunt, Brett (2017). Editorial comment to biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam. International Journal of Urology, 24 (4), 286-287. doi: 10.1111/iju.13305

Editorial comment to biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam

2017

Journal Article

Prostate cancer grading: a decade after the 2005 modified Gleason grading system

Delahunt, Brett, Grignon, David J., Samaratunga, Hemamali, Srigley, John R., Leite, Katia R. M., Kristiansen, Glen, Evans, Andrew J., Kench, James G. and Egevad, Lars (2017). Prostate cancer grading: a decade after the 2005 modified Gleason grading system. Archives of Pathology and Laboratory Medicine, 141 (2), 182-183. doi: 10.5858/arpa.2016-0300-LE

Prostate cancer grading: a decade after the 2005 modified Gleason grading system

2017

Conference Publication

Expression of prostate specific membrane antigen in clear cell renal cell carcinoma, neovasculature of tumour, and circulating tumour cells

Nicholson, C., Rhee, H., Ng, K. L., Tse, B. W., Yeh, M-C, Russell, P., Nelson, C., Thomas, P., Samaratunga, H., Vela, I., Gobe, G. and Wood, S. (2017). Expression of prostate specific membrane antigen in clear cell renal cell carcinoma, neovasculature of tumour, and circulating tumour cells. 70th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Canberra, ACT Australia, 24-27 February 2017. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/bju.13750

Expression of prostate specific membrane antigen in clear cell renal cell carcinoma, neovasculature of tumour, and circulating tumour cells

2016

Journal Article

Editorial statement on Gleason scoring for prostate cancer: in regard to Zietman et al

Egevad, Lars, Samaratunga, Hemamali, Srigley, John R. and Delahunt, Brett (2016). Editorial statement on Gleason scoring for prostate cancer: in regard to Zietman et al. International Journal of Radiation Oncology - Biology - Physics, 96 (5), 1126-1127. doi: 10.1016/j.ijrobp.2016.08.029

Editorial statement on Gleason scoring for prostate cancer: in regard to Zietman et al

2016

Journal Article

New Gleason grading system: statement from the editors of 6 journals

Egevad, Lars, Samaratunga, Hemamali, Srigley, John R. and Delahunt, Brett (2016). New Gleason grading system: statement from the editors of 6 journals. Urologic Oncology: Seminars and Original Investigations, 34 (11), 479-480. doi: 10.1016/j.urolonc.2016.07.003

New Gleason grading system: statement from the editors of 6 journals

2016

Journal Article

Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease

Rhee, Handoo, Ng, Keng Lim, Tse, Brian Wan-Chi, Yeh, Mei-Chun, Russell, Pamela J., Nelson, Colleen, Thomas, Paul, Samaratunga, Hemamali, Vela, Ian, Gobe, Glenda and Wood, Simon (2016). Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease. Pathology, 48 (6), 613-616. doi: 10.1016/j.pathol.2016.05.011

Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease

2016

Journal Article

One is the new six: the international society of urological pathology (ISUP) patient-focused approach to Gleason grading

Srigley, John R., Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamali, Yaxley, John and Evans, Andrew J. (2016). One is the new six: the international society of urological pathology (ISUP) patient-focused approach to Gleason grading. Canadian Urological Association Journal, 10 (9-10), 339-341. doi: 10.5489/cuaj.4146

One is the new six: the international society of urological pathology (ISUP) patient-focused approach to Gleason grading

2016

Journal Article

Reply by the authors

Egevad, Lars, Samaratunga, Hemamali, Srigley, John R. and Delahunt, Brett (2016). Reply by the authors. Urology, 96, 179-180. doi: 10.1016/j.urology.2016.07.006

Reply by the authors

2016

Journal Article

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study

Yaxley, John W., Coughlin, Geoffrey D., Chambers, Suzanne K., Occhipinti, Stefano, Samaratunga, Hema, Zajdlewicz, Leah, Dunglison, Nigel, Carter, Rob, Williams, Scott, Payton, Diane J., Perry-Keene, Joanna, Lavin, Martin F. and Gardiner, Robert A. (2016). Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. The Lancet, 388 (10049), 1057-1066. doi: 10.1016/S0140-6736(16)30592-X

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study

2016

Journal Article

Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists

Kweldam, Charlotte F., Nieboer, Daan, Algaba, Ferran, Amin, Mahul B., Berney, Dan M., Billis, Athanase, Bostwick, David G., Bubendorf, Lukas, Cheng, Liang, Comperat, Eva, Delahunt, Brett, Egevad, Lars, Evans, Andrew J., Hansel, Donna E., Humphrey, Peter A., Kristiansen, Glen, van der Kwast, Theodorus H., Magi-Galluzzi, Cristina, Montironi, Rodolfo, Netto, George J., Samaratunga, Hemamali, Srigley, John R., Tan, Puay H., Varma, Murali, Zhou, Ming and van Leenders, Geert J. L. H. (2016). Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists. Histopathology, 69 (3), 441-449. doi: 10.1111/his.12976

Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists

2016

Journal Article

From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer

Samaratunga, Hemamali, Delahunt, Brett, Yaxley, John, Srigley, John R. and Egevad, Lars (2016). From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer. Scandinavian Journal of Urology, 50 (5), 325-329. doi: 10.1080/21681805.2016.1201858

From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer

2016

Journal Article

Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocol

Roberts, Matthew J., Yaxley, John W., Coughlin, Geoffrey D., Gianduzzo, Troy R. J., Esler, Rachel C., Dunglison, Nigel T., Chambers, Suzanne K., Medcraft, Robyn J., Chow, Clement W. K., Schirra, Horst Joachim, Richards, Renee S., Kienzle, Nicholas, Lu, Macy, Brereton, Ian, Samaratunga, Hema, Perry-Keene, Joanna, Payton, Diane, Oyama, Chikara, Doi, Suhail A., Lavin, Martin F. and Gardiner, Robert A. (2016). Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocol. Contemporary Clinical Trials, 50, 16-20. doi: 10.1016/j.cct.2016.06.014

Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocol

2016

Journal Article

Prostate-based biofluids for the detection of prostate cancer: a comparative study of the diagnostic performance of cell-sourced RNA biomarkers

Roberts, Matthew J., Richards, Renee S., Chow, Clement W. K., Doi, Suhail A. R., Schirra, Horst Joachim, Buck, Marion, Samaratunga, Hemamali, Perry-Keene, Joanna, Payton, Diane, Yaxley, John, Lavin, Martin F. and Gardiner, Robert A. (2016). Prostate-based biofluids for the detection of prostate cancer: a comparative study of the diagnostic performance of cell-sourced RNA biomarkers. Prostate International, 4 (3), 97-102. doi: 10.1016/j.prnil.2016.04.002

Prostate-based biofluids for the detection of prostate cancer: a comparative study of the diagnostic performance of cell-sourced RNA biomarkers

2016

Journal Article

Consensus guidelines for reporting prostate cancer Gleason Grade

Egevad, Lars, Samaratunga, Hemamali, Srigley, John R. and Delahunt, Brett (2016). Consensus guidelines for reporting prostate cancer Gleason Grade. BJU International, 118 (3), E1-E2. doi: 10.1111/bju.13596

Consensus guidelines for reporting prostate cancer Gleason Grade

2016

Journal Article

Reply: Gleason and Fuhrman no longer make the grade

Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamli, Martignoni, Guido, Nacey, John N. and Srigley, John R. (2016). Reply: Gleason and Fuhrman no longer make the grade. Histopathology, 69 (2), 341-342. doi: 10.1111/his.12947

Reply: Gleason and Fuhrman no longer make the grade

2016

Journal Article

A systematic review and meta-Analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma

Ng, Keng Lim, Morais, Christudas, Bernard, Anne, Saunders, Nicholas, Samaratunga, Hemamali, Gobe, Glenda and Wood, Simon (2016). A systematic review and meta-Analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma. Journal of Clinical Pathology, 69 (8), 661-671. doi: 10.1136/jclinpath-2015-203585

A systematic review and meta-Analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma

2016

Journal Article

Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features

Seipel, Amanda H., Delahunt, Brett, Samaratunga, Hemamali and Egevad, Lars (2016). Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features. Pathology, 48 (5), 398-405. doi: 10.1016/j.pathol.2016.04.001

Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features

2016

Journal Article

Re: Anthony Zietman, Joseph Smith, Eric Klein, Michael Droller, Prokar Dasgupta, James Catto. Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now Required. Eur Urol 2016;70:1

Egevad, Lars, Samaratunga, Hemamali, Srigley, John R. and Delahunt, Brett (2016). Re: Anthony Zietman, Joseph Smith, Eric Klein, Michael Droller, Prokar Dasgupta, James Catto. Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now Required. Eur Urol 2016;70:1. European Urology, 71 (2), e52-e53. doi: 10.1016/j.eururo.2016.07.019

Re: Anthony Zietman, Joseph Smith, Eric Klein, Michael Droller, Prokar Dasgupta, James Catto. Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now Required. Eur Urol 2016;70:1

2016

Journal Article

Re: Consensus Guidelines for Reporting Prostate Cancer Gleason Grade: A. Zietman, E. Klein, M. J. Droller, P. Dasgupta, J. Catto and J. A. Smith, Jr. J Urol 2016; 195: 1723

Egevad, Lars, Samaratunga, Hemamali, Srigley, John R. and Delahunt, Brett (2016). Re: Consensus Guidelines for Reporting Prostate Cancer Gleason Grade: A. Zietman, E. Klein, M. J. Droller, P. Dasgupta, J. Catto and J. A. Smith, Jr. J Urol 2016; 195: 1723. Journal of Urology, 196 (4), 1321-1323. doi: 10.1016/j.juro.2016.07.069

Re: Consensus Guidelines for Reporting Prostate Cancer Gleason Grade: A. Zietman, E. Klein, M. J. Droller, P. Dasgupta, J. Catto and J. A. Smith, Jr. J Urol 2016; 195: 1723

2016

Journal Article

International Society of Urological Pathology (ISUP) grading of prostate cancer

Egevad, Lars, Delahunt, Brett, Evans, Andrew J., Grignon, David J., Kench, James G., Kristiansen, Glen, Leite, Katia R., Samaratunga, Hemamali and Srigley, John R. (2016). International Society of Urological Pathology (ISUP) grading of prostate cancer. American Journal of Surgical Pathology, 40 (6), 858-861. doi: 10.1097/PAS.0000000000000642

International Society of Urological Pathology (ISUP) grading of prostate cancer

Supervision

Availability

Professor Hemamali Samaratunga is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Professor Hemamali Samaratunga's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au